NHS England has asked NICE to consider approving a slow phased rollout of tirzepatide (Mounjaro) for weight loss in primary care to avoid overwhelming GPs. It follows draft recommendations from NICE ...
Who won the debate — Vance or Walz? Forty-two percent of debate watchers said Vance won the debate, while 41% thought Walz emerged as the winner. Seventeen percent called the debate a tie.